Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617807 · ClinicalTrials.gov registry record · NA
Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
A NA study of Meniscus Tear, sponsored by Marshall University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT05617807: Recruiting NA study of Meniscus Tear, sponsored by Marshall University.
NCT05617807 is a NA study of Meniscus Tear that is actively recruiting participants, run by Marshall University. The registered enrollment target is 100 participants, above the 77-participant average among 6 other Meniscus Tear trials with a reported enrollment target (30% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05617807, a NA study of Meniscus Tear, is actively recruiting participants, sponsored by Marshall University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Standard arthroscopy has been the gold standard for treatment of meniscus tears since the 1980's. The purpose of this study is to analyze the clinical outcomes of using the smaller diameter Nanoscope for partial menisectomy. The authors hypothesize that the Nanoscopic partial menisectomy patients will have less pain and return function faster than standard arthroscopy.
Conditions Studied
Interventions
- PROCEDURE Nanoscopic partial meniscectomy
- PROCEDURE Standard Partial Meniscectomy
Study Locations (2)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
West Virginia
- Marshall Orthopaedics - Teays Valley - Scott Depot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-12 |
| Phase | NA |
What NCT05617807 shows while recruiting
NCT05617807 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 77-participant average among 6 other Meniscus Tear trials with a reported enrollment target (30% higher).
The record links to 1 condition, with Meniscus Tear appearing as the primary indexed condition, and to 2 interventions - of which Nanoscopic partial meniscectomy is the first listed.
NCT05617807 reports a single indexed study location in District of Columbia, West Virginia.
Frequently Asked Questions
What is clinical trial NCT05617807 about?
NCT05617807 is a clinical study titled "Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy". Standard arthroscopy has been the gold standard for treatment of meniscus tears since the 1980's. The purpose of this study is to analyze the clinical outcomes of using the smaller diameter Nanoscope for partial menisectomy. The authors hypothesize that the Nanoscopic partial menisectomy patients wi...
What is the current status of trial NCT05617807?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-12-01. Estimated completion is 2024-12.
What conditions does trial NCT05617807 study?
This clinical trial studies the following conditions: Meniscus Tear.
What interventions are being tested in trial NCT05617807?
The interventions under investigation include: Nanoscopic partial meniscectomy (PROCEDURE), Standard Partial Meniscectomy (PROCEDURE).
Who is sponsoring clinical trial NCT05617807?
This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617807 being conducted?
This trial has 2 study locations across District of Columbia, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meniscus Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Bioactive Sleeve on Pain and PROMs
RECRUITING · NA
-
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
RECRUITING · NA
-
Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
RECRUITING · Phase 1
-
Dronabinol After Arthroscopic Surgery
RECRUITING · Phase 3
-
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
RECRUITING · Early Phase 1
-
Corticosteroid Meniscectomy Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI